MedTrace Logo

QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study

NCT05155553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1524

Last updated 2024-10-17

No results posted yet for this study

Summary

Study for performance evaluation of the QIAstat-Dx® Meningitis/Encephalitis Panel in comparison with other chosen comparator methods.

Conditions

  • Meningitis/Encephalitis

Interventions

DEVICE

QIAstat-Dx® Meningitis/Encephalitis (ME) Panel

The performance of QIAstat-Dx® Meningitis/Encephalitis Panel will be evaluated in comparison with another validated comparator method, followed by bidirectional sequencing using residual specimens of cerebrospinal fluid (CSF) obtained by lumbar puncture from subjects with signs and symptoms of meningitis and/or encephalitis.

Sponsors & Collaborators

  • QIAGEN Gaithersburg, Inc

    lead INDUSTRY

Principal Investigators

  • Sarah Johnson · QIAGEN Gaithersburg, Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-04
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155553 on ClinicalTrials.gov